Early treatment for Clostridioides difficile infection: retrospective cohort study

Area of Science:

• Infectious Diseases
• Clinical Medicine
• Epidemiology

Background:

• Clostridioides difficile infection (CDI) is a leading cause of infectious diarrhea.
• Current guidelines recommend empirical antibiotics for suspected CDI with delayed results or severe cases, based on limited evidence.
• The impact of early CDI treatment on patient outcomes requires further investigation.

Purpose of the Study:

• To evaluate the effect of early antibiotic initiation on mortality, length of hospital stay, recurrence, and colectomy rates in adult patients with CDI.
• To assess the clinical outcomes associated with early versus delayed treatment of Clostostridioides difficile infection.

Main Methods:

• Retrospective cohort study of 796 adult patients diagnosed with CDI.
• Early treatment defined as anti-Clostridioides medication within 24 hours of stool sampling.
• Propensity score matching and logistic regression used to control for confounding factors.

Main Results:

• No significant difference in 30-day or 90-day mortality between early and delayed treatment groups.
• No statistically significant differences observed in recurrence rates, ICU admissions, or colectomy rates.
• Patients receiving early treatment experienced a shorter length of hospital stay (6 days vs. 8 days).

Conclusions:

• Early treatment for CDI in adult patients is associated with a reduced length of hospital stay.
• Initiating treatment within 24 hours of stool sampling did not significantly alter mortality, recurrence, or colectomy rates.